A prospective randomized controlled trial of Baduanjin Exercise Rehabilitation on exercise tolerance in patients with chronic ejection fraction preserved heart failure
- Conditions
- Chronic heart failure with preserved ejection fraction
- Registration Number
- ITMCTR2000004041
- Lead Sponsor
- onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. According to the diagnostic criteria of ejection fraction preserved heart failure;
2. NYHA was grade I - III;
3. Aged 30 to 80 years old;
4. During the observation period, other drugs beyond the regulations are not applicable, and those who can persist in completing the treatment and the detection of the observation indexes can be adhered to;
5. Consent to participate in clinical trial observation, sign informed consent and date.
1. Combined with atrial fibrillation;
2. Valvular heart disease, restrictive cardiomyopathy and pericardial disease;
3. Decompensated heart failure is unstable after treatment;
4. At the same time, severe lung, liver, endocrine system and renal dysfunction were accompanied;
5. Cancer and other common malignant diseases reduce life expectancy;
6. Pregnant or lactating women;
7. Allergic constitution or allergy to common drugs;
8. Patients with mental illness or poor treatment compliance.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method VO2peak;Six minute walk test;
- Secondary Outcome Measures
Name Time Method Heart rate variability;VE/VCO2 slope;Oxygen uptake efficiency slope, OUES;maximal inspiratory pressure, MIP;Exercise oscillatory ventilation, EOV;Anaerobic threshold;